Series C+ Biotech & Life Sciences investors in Europe

81 funds

Gatsbie lists 81 Biotech & Life Sciences investors headquartered in Europe that invest at Series C+ stage (as of 2026-10-24).

49 name biotech & life sciences in their investment focus; 32 invest across sectors.

Most are based in United Kingdom (35), Germany (13) and France (10); the most common kinds of capital are Venture equity (65), Growth equity (41) and Buyout (26).

See all 81 with thesis, portfolio and contacts Sign up free

20 of 81 funds

3T Family Office Ltd
Geneva, Switzerland
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Financial Services, Healthcare & MedTech, Consumer Apps, Media & Entertainment
Abingworth
London, United Kingdom
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Healthcare & MedTech, Hardware & IoT, Biotech & Life Sciences, Developer Tools
Advent Life Sciences
London, United Kingdom
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Biotech & Life Sciences, Hardware & IoT, Healthcare & MedTech
Aescap Venture
Amsterdam, Netherlands
Stages: Pre-Seed, Seed, Series A, Series C+
Sectors: Hardware & IoT, Healthcare & MedTech, Biotech & Life Sciences
BIO
Brussels, Belgium
Stages: Series C+, Growth
Sectors: Developer Tools, Financial Services, AgTech & FoodTech, Artificial Intelligence
BlueYard
Berlin, Germany
Stages: Pre-Seed, Seed, Series A, Series C+
Sectors: Artificial Intelligence, Cryptocurrency & Blockchain, Developer Tools, Financial Services
Bpifrance
Paris, France
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Biotech & Life Sciences, Hardware & IoT, Healthcare & MedTech, CleanTech & Climate
British Business Bank
Sheffield, United Kingdom
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Biotech & Life Sciences
British Business Bank
Sheffield, United Kingdom
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Biotech & Life Sciences, Financial Services
CREADEV
Paris, France
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Healthcare & MedTech, AgTech & FoodTech, CleanTech & Climate, Investment
Delton AG
Bad Homburg, Germany
Stages: Series C+, Growth
Sectors: Healthcare & MedTech, Artificial Intelligence, Biotech & Life Sciences
Enterprise Ventures (EV)
Aberdeen, United Kingdom
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Biotech & Life Sciences, Healthcare & MedTech, Mobility & Transportation, AgTech & FoodTech
Fountain Healthcare Partners
Dublin, Ireland
Stages: Pre-Seed, Seed, Series A, Series C+
Sectors: Biotech & Life Sciences, Healthcare & MedTech, Hardware & IoT
Gilde Healthcare
Utrecht, Netherlands
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Healthcare & MedTech, Biotech & Life Sciences, CleanTech & Climate, Data & Analytics
GO CAPITAL
Rennes, France
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Biotech & Life Sciences, Hardware & IoT, Healthcare & MedTech, CleanTech & Climate
HBM Healthcare Investments
Zug, Switzerland
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Hardware & IoT, Healthcare & MedTech, Biotech & Life Sciences
HSBC Innovation Banking
London, United Kingdom
Stages: Seed, Series A, Series C+, Growth
Sectors: Biotech & Life Sciences, Healthcare & MedTech, Financial Services, Hardware & IoT
InnovationsKapital Nordic Advisors AB
Göteborg, Sweden
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Healthcare & MedTech, Biotech & Life Sciences, Hardware & IoT
INTERGROUP PARTNERS AG
Schindellegi, Switzerland
Stages: Seed, Series C+
Sectors: Cybersecurity, Developer Tools, Space & Aerospace, Hardware & IoT
IP Group plc
London, United Kingdom
Stages: Pre-Seed, Seed, Series A, Series B
Sectors: Healthcare & MedTech, Biotech & Life Sciences

See all 81 Biotech & Life Sciences investors in Investor Discovery

Other stages

Biotech & Life Sciences investors elsewhere

Other sectors in Europe

Counted by where each fund is headquartered, from public sources, as of 2026-10-24. Funds that invest across sectors are included, as in Investor Discovery.